{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T06:11:11Z","timestamp":1790835071429,"version":"4.1.0"},"reference-count":16,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2025,7,25]]},"DOI":"10.7759\/cureus.88785","type":"journal-article","created":{"date-parts":[[2025,7,26]],"date-time":"2025-07-26T06:40:07Z","timestamp":1753512007000},"source":"Crossref","is-referenced-by-count":1,"title":["Transplant-Associated Thrombotic Microangiopathy After Autologous Hematopoietic Stem Cell Transplantation Treated With Eculizumab"],"prefix":"10.7759","author":[{"given":"Taichiro","family":"Tokura","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Youhei","family":"Imai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Reina","family":"Saga","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiroko","family":"Hidai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sayuri","family":"Motomura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1182\/hematology.2024000545","article-title":"Transplant-associated TMA: the conundrum of diagnosis and treatment","volume":"2024","author":"Li A","year":"2024","unstructured":"Li A, Sartain SE. Transplant-associated TMA: the conundrum of diagnosis and treatment. Hematology Am Soc Hematol Educ Program. 2024, 2024:206-13. 10.1182\/hematology.2024000545","journal-title":"Hematology Am Soc Hematol Educ Program"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1002\/ajh.26872","article-title":"Reeling in complement in transplant-associated thrombotic microangiopathy: you're going to need a bigger boat","volume":"98 Suppl 4","author":"Jodele S","year":"2023","unstructured":"Jodele S, Sabulski A. Reeling in complement in transplant-associated thrombotic microangiopathy: you're going to need a bigger boat. Am J Hematol. 2023, 98 Suppl 4:S57-73. 10.1002\/ajh.26872","journal-title":"Am J Hematol"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1016\/j.jtct.2022.01.009","article-title":"Incidence and risk factors of transplantation-associated thrombotic microangiopathy: a systematic review and meta-analysis","volume":"28","author":"Van Benschoten V","year":"2022","unstructured":"Van Benschoten V, Roy C, Gupta R, Ouellette L, Hingorani S, Li A. Incidence and risk factors of transplantation-associated thrombotic microangiopathy: a systematic review and meta-analysis. Transplant Cell Ther. 2022, 28:266.e1-8. 10.1016\/j.jtct.2022.01.009","journal-title":"Transplant Cell Ther"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbmt.2019.06.006","article-title":"Risk factors for transplant-associated thrombotic microangiopathy after autologous hematopoietic cell transplant in high-risk neuroblastoma","volume":"25","author":"Tolbert VP","year":"2019","unstructured":"Tolbert VP, Dvorak CC, Golden C, et al.. Risk factors for transplant-associated thrombotic microangiopathy after autologous hematopoietic cell transplant in high-risk neuroblastoma. Biol Blood Marrow Transplant. 2019, 25:2031-9. 10.1016\/j.bbmt.2019.06.006","journal-title":"Biol Blood Marrow Transplant"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1182\/bloodadvances.2020003455","article-title":"A pragmatic multi-institutional approach to understanding transplant-associated thrombotic microangiopathy after stem cell transplant","volume":"5","author":"Dandoy CE","year":"2021","unstructured":"Dandoy CE, Rotz S, Alonso PB, et al.. A pragmatic multi-institutional approach to understanding transplant-associated thrombotic microangiopathy after stem cell transplant. Blood Adv. 2021, 5:1-11. 10.1182\/bloodadvances.2020003455","journal-title":"Blood Adv"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2015-08-663435","article-title":"The genetic fingerprint of susceptibility for transplant-associated thrombotic microangiopathy","volume":"127","author":"Jodele S","year":"2016","unstructured":"Jodele S, Zhang K, Zou F, et al.. The genetic fingerprint of susceptibility for transplant-associated thrombotic microangiopathy. Blood. 2016, 127:989-96. 10.1182\/blood-2015-08-663435","journal-title":"Blood"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1016\/j.jtct.2022.11.015","article-title":"Harmonizing definitions for diagnostic criteria and prognostic assessment of transplantation-associated thrombotic microangiopathy: a report on behalf of the European Society for Blood and Marrow Transplantation, American Society for Transplantation and Cellular Therapy, Asia-Pacific Blood and Marrow Transplantation Group, and Center for International Blood and Marrow Transplant Research","volume":"29","author":"Schoettler ML","year":"2023","unstructured":"Schoettler ML, Carreras E, Cho B, et al.. Harmonizing definitions for diagnostic criteria and prognostic assessment of transplantation-associated thrombotic microangiopathy: a report on behalf of the European Society for Blood and Marrow Transplantation, American Society for Transplantation and Cellular Therapy, Asia-Pacific Blood and Marrow Transplantation Group, and Center for International Blood and Marrow Transplant Research. Transplant Cell Ther. 2023, 29:151-63. 10.1016\/j.jtct.2022.11.015","journal-title":"Transplant Cell Ther"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.3390\/ph15070845","article-title":"Complement system as a new target for hematopoietic stem cell transplantation-related thrombotic microangiopathy","volume":"15","author":"Ardissino G","year":"2022","unstructured":"Ardissino G, Capone V, Tedeschi S, Porcaro L, Cugno M. Complement system as a new target for hematopoietic stem cell transplantation-related thrombotic microangiopathy. Pharmaceuticals (Basel). 2022, 15:845. 10.3390\/ph15070845","journal-title":"Pharmaceuticals (Basel)"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2020.564647","article-title":"Efficacy and safety of eculizumab in the treatment of transplant-associated thrombotic microangiopathy: a systematic review and meta-analysis","volume":"11","author":"Zhang R","year":"2020","unstructured":"Zhang R, Zhou M, Qi J, Miao W, Zhang Z, Wu D, Han Y. Efficacy and safety of eculizumab in the treatment of transplant-associated thrombotic microangiopathy: a systematic review and meta-analysis. Front Immunol. 2020, 11:564647. 10.3389\/fimmu.2020.564647","journal-title":"Front Immunol"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbmt.2005.04.007","article-title":"Sirolimus and thrombotic microangiopathy after allogeneic hematopoietic stem cell transplantation","volume":"11","author":"Cutler C","year":"2005","unstructured":"Cutler C, Henry NL, Magee C, et al.. Sirolimus and thrombotic microangiopathy after allogeneic hematopoietic stem cell transplantation. Biol Blood Marrow Transplant. 2005, 11:551-7. 10.1016\/j.bbmt.2005.04.007","journal-title":"Biol Blood Marrow Transplant"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbmt.2012.10.006","article-title":"Thrombotic microangiopathy associated with sirolimus level after allogeneic hematopoietic cell transplantation with tacrolimus\/sirolimus-based graft-versus-host disease prophylaxis","volume":"19","author":"Shayani S","year":"2013","unstructured":"Shayani S, Palmer J, Stiller T, et al.. Thrombotic microangiopathy associated with sirolimus level after allogeneic hematopoietic cell transplantation with tacrolimus\/sirolimus-based graft-versus-host disease prophylaxis. Biol Blood Marrow Transplant. 2013, 19:298-304. 10.1016\/j.bbmt.2012.10.006","journal-title":"Biol Blood Marrow Transplant"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2014-03-564997","article-title":"Diagnostic and risk criteria for HSCT-associated thrombotic microangiopathy: a study in children and young adults","volume":"124","author":"Jodele S","year":"2014","unstructured":"Jodele S, Davies SM, Lane A, et al.. Diagnostic and risk criteria for HSCT-associated thrombotic microangiopathy: a study in children and young adults. Blood. 2014, 124:645-53. 10.1182\/blood-2014-03-564997","journal-title":"Blood"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1097\/TP.0b013e3181f24e8d","article-title":"Validation of recently proposed consensus criteria for thrombotic microangiopathy after allogeneic hematopoietic stem-cell transplantation","volume":"90","author":"Cho BS","year":"2010","unstructured":"Cho BS, Yahng SA, Lee SE, et al.. Validation of recently proposed consensus criteria for thrombotic microangiopathy after allogeneic hematopoietic stem-cell transplantation. Transplantation. 2010, 90:918-26. 10.1097\/TP.0b013e3181f24e8d","journal-title":"Transplantation"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1038\/s41409-021-01283-0","article-title":"Transplant-associated thrombotic microangiopathy: theoretical considerations and a practical approach to an unrefined diagnosis","volume":"56","author":"Young JA","year":"2021","unstructured":"Young JA, Pallas CR, Knovich MA. Transplant-associated thrombotic microangiopathy: theoretical considerations and a practical approach to an unrefined diagnosis. Bone Marrow Transplant. 2021, 56:1805-17. 10.1038\/s41409-021-01283-0","journal-title":"Bone Marrow Transplant"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1016\/j.jtct.2022.09.026","article-title":"Pulmonary manifestations and vascular changes in pediatric transplantation-associated thrombotic microangiopathy","volume":"29","author":"Schoettler ML","year":"2023","unstructured":"Schoettler ML, Saldana BD, Berkenkamp L, et al.. Pulmonary manifestations and vascular changes in pediatric transplantation-associated thrombotic microangiopathy. Transplant Cell Ther. 2023, 29:45.e1-8. 10.1016\/j.jtct.2022.09.026","journal-title":"Transplant Cell Ther"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbmt.2012.08.022","article-title":"Pulmonary arterial hypertension in pediatric patients with hematopoietic stem cell transplant-associated thrombotic microangiopathy","volume":"19","author":"Jodele S","year":"2013","unstructured":"Jodele S, Hirsch R, Laskin B, Davies S, Witte D, Chima R. Pulmonary arterial hypertension in pediatric patients with hematopoietic stem cell transplant-associated thrombotic microangiopathy. Biol Blood Marrow Transplant. 2013, 19:202-7. 10.1016\/j.bbmt.2012.08.022","journal-title":"Biol Blood Marrow Transplant"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/381093-transplant-associated-thrombotic-microangiopathy-after-autologous-hematopoietic-stem-cell-transplantation-treated-with-eculizumab","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,7,26]],"date-time":"2025-07-26T06:40:08Z","timestamp":1753512008000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/381093-transplant-associated-thrombotic-microangiopathy-after-autologous-hematopoietic-stem-cell-transplantation-treated-with-eculizumab"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7,25]]},"references-count":16,"URL":"https:\/\/doi.org\/10.7759\/cureus.88785","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2025,7,25]]}}}